Asthma Trial, Recruiting NCT05608668 Sponsor: Duke University Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT05608668
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children between 8 and 17 years old who have obesity (a body weight that falls at or above the 95th percentile for their age and sex) and mild asthma.
  • The child's parent or legal guardian must give written permission for them to take part, and the child must also agree to participate.
  • The child and their parent or guardian must be able to speak and read English.
  • The family must have access to the internet and a smartphone or computer that meets the study's requirements.
  • The child must have a parent, guardian, or designated caregiver who is willing to support and encourage them throughout the study.
  • The child must currently be taking a prescription asthma medication, such as albuterol (a rescue inhaler) or an inhaled steroid.

Who may not be able to join:

  • Children who have ever been put on a breathing machine (ventilator) due to a severe asthma attack.
  • Anyone who is currently pregnant or planning to become pregnant.
  • Children whose lung function test results fall below a certain level at the screening visit (confirm with trial site).
  • Anyone who has had lung surgery in the past two years.
  • Anyone who has had a blood clot in the lungs (pulmonary embolism) in the past two years.
  • Anyone who has ever had repeated collapsed lungs, or a collapsed lung within the past 12 months.
  • Anyone who currently has chest pain that has not been explained or diagnosed by a doctor.
  • Anyone who has had inner ear surgery in the past 12 months.
  • Anyone who has had unexplained fainting episodes in the past two years.
  • Anyone with a progressive condition affecting the nerves or muscles, or who needs ongoing oxygen therapy.
  • Anyone who is unable to complete the starting measurements of the study to the satisfaction of the research team.
  • Anyone who, in the opinion of the lead researcher, has any condition that could make it unsafe for them to take part in study activities — such as a physical disability, a recent injury, or unexplained heart, lung, or nerve symptoms (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jason Lang, MD, Duke University

Phone: 9197041523

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
27 July 2023
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Adherence to active IMR Adherence to active IMR; Participant satisfaction among active IMR participants; Prevalence of completer status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov